Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol

a technology of arsenic trioxide and arsenic trioxide, which is applied in the field of producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol, can solve the problems of well-known toxicity of arsenic trioxide, and achieve the effect of improving the quality of life of patients
US20030099719A1Inactive Publication Date: 2003-05-29MEMORIAL SLOAN KETTERING CANCER CENT

Patent Information

Authority / Receiving Office
US ยท United States
Patent Type
Applications(United States)
Current Assignee / Owner
MEMORIAL SLOAN KETTERING CANCER CENT
Publication Date
2003-05-29
Estimated Expiration
Not applicable ยท inactive patent
Patent Text Reader

Abstract

The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Need to check novelty before this filing date? Find Prior Art

Description

1. FIELD OF INVENTION

[0001] The present invention relates to methods and compositions for the treatment of leukemia, lymphoma, and certain other cancers.

[0002] More specifically, the present invention relates to the novel uses of arsenic trioxide and an organic arsenic compound for treating acute leukemia and chronic leukemia.2. BACKGROUND OF THE INVENTION2.1. Cancer

[0003] Cancer is characterized primarily by an increase in the number of abnormal cells derived from a given normal tissue, invasion of adjacent tissues by these abnormal cells, and lymphatic or blood-borne spread of malignant cells to regional lymph nodes and to distant sites (metastasis). Clinical data and molecular biologic studies indicate that cancer is a multistep process that begins with minor preneoplastic changes, which may under certain conditions progress to neoplasia.

[0004] Pre-malignant abnormal cell growth as exemplified by hyperplasia, metaplasia, and dysplasia (for review of such abnormal growth condition...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More